Prometheus Biosciences Inc 's ability to collect accounts receivable sequentially worsen to 4.17, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Prometheus Biosciences Inc 's Accounts Receivable average collection period in the Mar 31 2023 quarter, has increased to 88 days, from 69 days, in the Dec 31 2022 quarter.

If we take a look into Healthcare sector 504 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2023 from 3154 to 3195.

What is Receivable Turnover Ratio?
What is Prometheus Biosciences Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RXDX Receivables Turnover Ratio	(Mar 31 2023) III. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter
Y / Y Receivable Change	-	-4.63 %	38.59 %	759.45 %	32.37 %
Y / Y Revenue Change	-71.8 %	-37.03 %	-3.78 %	289.26 %	415.66 %
Receivable Turnover Ratio (TTM)	4.17	5.32	5.56	5.89	7.71
RXDX's Total Ranking	# 3195	# 3154	# 3179	# 3188	# 4218
Accounts Receivable average collection period days	88	69	66	62	47
Seq. Receivable Change	-	9.35 %	-49.54 %	44.8 %	19.37 %
Seq. Revenue Change	69.22 %	-32.54 %	-23.72 %	-67.62 %	277.92 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 174
Healthcare Sector	# 505
Overall Market	# 3195

Receivable Turnover Ratio Statistics
High	Average	Low
7.71	5.48	4.17
(Mar 31 2022)		(Mar 31 2023)

RXDX Company Profile • Back to RXDX Efficiency Comparisons • Compare RXDX Receivables Turnover Ratio to its Competitors

Financial Statements
Prometheus Biosciences Inc 's Accounts Receivable	$ 0 Millions	Visit RXDX's Balance sheet
Prometheus Biosciences Inc 's Sales TTM	$ 4 Millions	Visit RXDX's Income Statement
Sources of RXDX's Revenues		Visit RXDX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
RXDX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
RXDX's Growth Rates	RXDX's Roa	RXDX's Inventory Turnover Ratio	RXDX's Dividend Comparisons
RXDX's Profitability Ratios	RXDX's Roi	RXDX's Asset Turnover Ratio	RXDX's Dividend Growth
RXDX's Valuation Ratios	RXDX's Roe	RXDX's Financial Strength Ratios	RXDX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Mar 31 2023

Receivable at quarter ending Mar 31 2023

Date modified: 2026-08-29T17:43:06+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.